C47.10, Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder

CGS-J15-L38822, MolDX: Minimal Residual Disease Testing for Cancer

J15

CGS-J15-L40225, MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer

J15

CGS-J15-L38067, MolDX: Next-Generation Sequencing for Solid Tumors

J15

CGS-J15-L38065, MolDX: Plasma-Based Genomic Profiling in Solid Tumors

J15

CGS-J18-L38065, MolDX: Plasma-Based Genomic Profiling in Solid Tumors

J18

CGS-J18-L38822, MolDX: Minimal Residual Disease Testing for Cancer

J18

CGS-J18-L38067, MolDX: Next-Generation Sequencing for Solid Tumors

J18

CGS-J18-L40225, MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer

J18

WPS-J5-L38158, MolDX: Next-Generation Sequencing for Solid Tumors

J5

A58756, Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

J5

A57858, Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors

J5

WPS-J5-L39040, MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

J5

A58468, Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers

J5

WPS-J5-L38835, MolDX: Minimal Residual Disease Testing for Cancer

J5

WPS-J5-L40277, MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer

J5

A52450, Billing and Coding: Paclitaxel (e.g., Taxol/Abraxane ™)

J6

NGS-J6-L37810, Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms

J6

NGS-J6-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

J6

A56867, Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms

J6

WPS-J8-L40277, MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer

J8